Product limit estimation for infectious disease data when the diagnostic test for the outcome is measured with uncertainty
From MaRDI portal
Publication:4521879
DOI10.1093/biostatistics/1.3.341zbMath0958.62104OpenAlexW2116461684WikidataQ30819788 ScholiaQ30819788MaRDI QIDQ4521879
Barbra A. Richardson, James P. Hughes
Publication date: 8 April 2001
Published in: Biostatistics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1093/biostatistics/1.3.341
Applications of statistics to biology and medical sciences; meta analysis (62P10) Nonparametric estimation (62G05) Estimation in survival analysis and censored data (62N02)
Related Items (12)
Integrative survival analysis with uncertain event times in application to a suicide risk study ⋮ Accounting for dependent errors in predictors and time-to-event outcomes using electronic health records, validation samples and multiple imputation ⋮ Regression analysis of misclassified current status data with informative observation times ⋮ Semiparametric probit regression model with misclassified current status data ⋮ Incorporating diagnostic accuracy into the estimation of discrete survival function ⋮ Repeated responses in misclassification binary regression: A Bayesian approach ⋮ Survival Weibull regression model for mismeasured outcomes ⋮ Nonparametric discrete survival function estimation with uncertain endpoints using an internal validation subsample ⋮ Non-parametric maximum likelihood estimation of interval-censored failure time data subject to misclassification ⋮ Regression analysis of misclassified current status data ⋮ Discrete Proportional Hazards Models for Mismeasured Outcomes ⋮ Interval-censored data with misclassification: a Bayesian approach
This page was built for publication: Product limit estimation for infectious disease data when the diagnostic test for the outcome is measured with uncertainty
